Caldiamide sodium

CAS : 131410-50-9

Ref. 3D-GFA41050

Informations sur le produit

• Nom: Caldiamide sodium
• Synonymes: 2,5,8,11-Tetraazatridecan-13-oic acid, 5,8-bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-, calcium complex, Calciate(1-), [5,8-bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oato(3-)]-, sodium, Calciate(1-), [5,8-bis[(carboxy-κO)methyl]-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oato(3-)-κN⁵,κN⁸,κN¹¹,κO¹³]-, sodium, Calciate(1-), [5,8-bis[(carboxy-κO)methyl]-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oato(3-)-κN⁵,κN⁸,κN¹¹,κO¹³]-, sodium (1:1), Calcium Sodium 5,8-Bis(Carboxylatomethyl)-11-[2-(Methylamino)-2-Oxoethyl]-3-Oxo-2,5,8,11-Tetraazatridecan-13-Oate (1:1:1) (Non-Preferred Name), Ccris 6697, Dv-7572

Description

Caldiamide sodium is a soluble organic solvent that has been used in targeted drug delivery. It has been shown to be effective in the treatment of glomerulopathy, with a dose-dependent reduction in proteinuria and regression of renal lesions. Caldiamide sodium may also have therapeutic potential for the treatment of other conditions, such as lupus nephritis, where it may modulate the immune system. The mechanism of action is not fully understood but is thought to involve metal chelate modulation and/or intra-articular injection.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 479.5 g/mol
• Formule: C₁₆H₂₆CaN₅NaO₈
• Degré de pureté: Min. 95%